Evolva Holding SA (EVE.SW)

CHF 0.84

(-6.44%)

Total Debt Summary of Evolva Holding SA

  • Evolva Holding SA's latest annual total debt in 2023 was - CHF , down -100.0% from previous year.
  • Evolva Holding SA's latest quarterly total debt in 2024 Q2 was - CHF , down 0.0% from previous quarter.
  • Evolva Holding SA reported annual total debt of 15.05 Million CHF in 2022, up 38.92% from previous year.
  • Evolva Holding SA reported annual total debt of 10.83 Million CHF in 2021, up 20.13% from previous year.
  • Evolva Holding SA reported quarterly total debt of - CHF for 2023 FY, down -100.0% from previous quarter.
  • Evolva Holding SA reported quarterly total debt of - CHF for 2023 Q4, down 0.0% from previous quarter.

Annual Total Debt Chart of Evolva Holding SA (2023 - 2005)

Historical Annual Total Debt of Evolva Holding SA (2023 - 2005)

Year Total Debt Total Debt Growth
2023 - CHF -100.0%
2022 15.05 Million CHF 38.92%
2021 10.83 Million CHF 20.13%
2020 9.02 Million CHF 47.21%
2019 6.12 Million CHF 93.0%
2018 3.17 Million CHF -0.17%
2017 3.18 Million CHF -29.97%
2016 4.54 Million CHF -10.97%
2015 5.1 Million CHF -34.42%
2014 7.77 Million CHF 4.52%
2013 7.44 Million CHF -13.26%
2012 8.58 Million CHF 109.15%
2011 4.1 Million CHF -0.37%
2010 4.11 Million CHF -56.57%
2009 9.48 Million CHF 0.0%
2008 - CHF -100.0%
2007 5.44 Million CHF -0.54%
2006 5.47 Million CHF 0.0%
2005 - CHF 0.0%

Peer Total Debt Comparison of Evolva Holding SA

Name Total Debt Total Debt Difference
Addex Therapeutics Ltd 344.33 Thousand CHF 100.0%
BB Biotech AG 304.9 Million CHF 100.0%
Basilea Pharmaceutica AG 128.6 Million CHF 100.0%
Idorsia Ltd 1.2 Billion CHF 100.0%
Kuros Biosciences AG 5.51 Million CHF 100.0%
Molecular Partners AG 3.65 Million CHF 100.0%
Relief Therapeutics Holding AG 4.31 Million CHF 100.0%
Santhera Pharmaceuticals Holding AG 25.06 Million CHF 100.0%